LATEST UPDATES » Vol 26, Nos. 09 & 10, September & October 2022 – Toxins and Medicines – Two Sides of the Same Coin       » Utilising Metal Nanoparticles as Plant Growth Regulators to Improve Crop Yield       » Remedy or Poison? How Microplastics Influence Copper Ion Toxicity in Aquatic Plants       » Synthesising Schiff Base Antimicrobial Copper Complexes With Unprecedented Speed       » Enhancing the Understanding of Past Infections With Machine Learning       » Mini, Cellular Bioweapons: Understanding the Structure and Mechanism of Stinging in Sea Anemone Nematocysts       » Converting Dead Spiders Into Gripping Tools
Vol 19, No. 09, September 2015   |   Issue PDF view/purchase
The 10-mins Interview with Dr. Patel on Philippines Healthcare & his new digital platform, MyDoc.
Dr. Patel is a Managing Director at Saena Partners, the Singapore-based investment entity that is one of the founders of MyDoc, and is responsible for business strategy and execution at the company. Regarded as a regional expert in startup incubation, he was previously a Senior Vice President at Chandler Corporation, a multi-billion dollar investment fund based in Singapore. In this role, he founded and led the investment team responsible for investing in healthcare businesses in South and Southeast Asia. His responsibilities included leading the on-the-ground incubation and early growth of a regional healthcare chain, as well as serving on the boards of several early-stage healthcare and education businesses throughout the region.

Prior to moving to Singapore in 2008, Dr. Patel practiced law at Cravath, Swaine & Moore, LLP in New York. He received an MD from the Columbia University College of Physicians and Surgeons and a JD from Columbia Law School. Upon graduation, he served as a Clinical Fellow at the Harvard Medical School, and was offered a Fulbright scholarship to study the differences between the Singaporean and US healthcare systems. Dr. Patel was a featured speaker at the 2011 Milken Global Conference and is a member of the Society of Kauffman Fellows. The following interview was conducted by Rachel Lim.

R: What is the current landscape of the Philippines healthcare and what are some of the advantages and disadvantages of this?

P: One of the interesting features of the Philippines healthcare system is the decentralized nature of the system. Given the history of government healthcare decentralizing in the early 1990s accompanied by the rise of the private integrated hospitals, patients, in theory, have many different options where they may receive care. In practice, however, the fragmentation in the market can prove challenging to patients.

Another notable feature of the healthcare system is the high level of out-of-pocket payments that occur in the Philippines as compared to its neighbors, a number close to half of total health expenditure. Recent changes in PhilHealth have helped lessen the burden, but this high out-of-pocket amount can help explain why many Filipinos tend to be more particular in their choice of provider, which, at least in the metro areas where there is a robust ecosystem of medical facilities, can lead to positive competitive pressures.

So, though decentralization and high out-of-pocket costs have created issues around fragmentation and cost burdens, it is creating an interesting space where patients are willing to make healthcare providers compete for their ‘business,’ and hence innovative solutions can potentially take root easier.

R: What kind of business does MyDoc focus on? How does the integrated healthcare system that MyDoc has developed work?

P: MyDoc is a digital platform for healthcare communications and care management. We provide medical providers and patients with a secure platform for virtual consultations by voice, video or text; peer-to-peer messaging with e-referrals; virtual appointment scheduling; and personal health diaries with diagnostics and personal health device integration.

We believe that we are well-placed to help manage the fragmentation of the Philippines healthcare market by creating a virtual care team. Some distinct use cases include: 1) the creation of ‘virtual clinics’ which is what we’ve done in our work with Guardian Health & Beauty (https://www.guardian.com.sg/Mydoc); 2) remote monitoring to improve post-operative care; 3) health management programs which begin with a health screening of a large number of people (employees or other participants). We help aggregate and analyze the health screening results of the participants, including connecting them virtually with doctors and other care givers. So far, in our work with employers and other groups, we have been able to dramatically increase the participation rates of these patients in following up their results, thus driving the use of vital health management programs; 4) peer-to-peer communications between healthcare professionals to help professionals share medical insights and assessments with colleagues, including e-referrals, all in a PDPA compliant system.

R: How will this integrated healthcare system help the Philippines healthcare landscape?

P: We feel that this system will make it much easier for patients to be able to receive the care that they need in a time and place that is convenient for them. This can only happen with an integrated approach, by including doctors, diagnostics, patients and payors. For example, diabetes is becoming a larger issue in the Philippines, but the number of endocrinologists able to treat these patients is quite small compared to the broader population. Our system allows the endocrinologist to manage a larger number of patients by automating a number of the tasks that are easily handled by our system.

R: What are some of the advantages of this healthcare system?

P: Given the high out-of-pocket costs that are part of the healthcare system currently, we will be able to drive costs lower for patients while at the same time helping allocate scarce resources more efficiently.

R: How do you hope to further develop this system in the future?

P: We intend to further develop our platform and provide easy access to third party content that can help manage conditions like diabetes and hypertension. But, we are very keen on listening to our users and making sure that our product can work best to deal with their main issues. It is a key benefit of a small company that moves fast – we can be very responsive to our users.

What Has Covid Ever Done for Us?
news 2022 PDA Aseptic Processing of Biopharmaceuticals Conference
news Thailand LAB INTERNATIONAL, Bio Asia Pacific, and FutureCHEM INTERNATIONAL are ready to offer the Science and Technology Industry complete solutions this September!
news Better together: registration opens for Vitafoods Asia 2022 co-located with Fi Asia in October
news 2022 PDA Pharmaceutical Manufacturing & Quality Conference

About Us
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   [email protected] or Ms Carmen Chan
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   [email protected]
Copyright© 2022 World Scientific Publishing Co Pte Ltd  •  Privacy Policy